That is the answer to: the likelihood of Cynata finishing the FDA P2 trial after their announcements in 2021.
KK made a comment dismissing cartridge regrowth in the OA trial. I found that interesting. Then a found an article that indicates perhaps why he would state that. Then you wrote some other off topic BS. Then you won the argument. Because you hold CYP stock.
Bravo.
CYP Price at posting:
22.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)